A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

April 29, 2016

Primary Completion Date

January 15, 2018

Study Completion Date

September 1, 2020

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Trifluridine/tipiracil + bevacizumab

Patients were treated withTrifluridine/tipiracil + bevacizumab regimen until they met a discontinuation criterion.

DRUG

Capecitabine + bevacizumab

Patients were treated with capecitabine+ bevacizumab regimen until they met a discontinuation criterion.

Trial Locations (57)

2100

Rigshospitalet - Dpt of Oncology, Copenhagen

3000

UZ Leuven Campus Gasthuisberg Digestieve Oncologie, Leuven

4000

CHC Saint-Joseph Oncologie-Hématoimmunopathologie, Liège

5000

Odense Universitetshospital - Department of Oncology, Odense

6000

Grand Hôpital de Charleroi Oncologie-Hématologie, Charleroi

10707

Onkologische Schwerpunktpraxis Kurfürstendamm, Berlin

14004

Hospital Universitario Reina Sofia, Deparatmento Oncología Médica, Córdoba

16132

A.O.U. SanMartino-IST, Unità Operativa Oncologia Medica 1, Genova

20162

A.O. Ospedale Niguarda Ca' Granda-Milano, Department of Onco-Haematology- Onoclogia Falck, Milan

25030

CHU Jean Minjoz, Service d'oncologie médicale, Besançon

25124

Fondazione Poliambulanza Istituto Ospedaliero, Clinical Oncology, Brescia

28007

Hospital Universitario Gregorio Maranon, Madrid

28034

Hospital Ramón y Cajal, Oncología Médica, Madrid

28046

H. Universitario La Paz Oncología Médica, Madrid

29010

Hospital General Universitario, Oncología Médica, Málaga

31008

Complejo Hospitalario de Navarra, Oncología Médica, Pamplona

39104

Schwerpunktpraxis für Hämatologie und Onkologie, Magdeburg

44805

Centre René Gauducheau, Oncologie Médicale, Saint-Herblain

56126

.O.U. Pisana-Ospedale Santa Chiara, U.O. di Oncologia Medica 2, Pisa

75012

Hôpital Saint Antoine, oncology department, Paris

80131

Seconda Università degli Studi di Napoli, U.O.C. di Oncologia Medica ed Ematologia, Naples

81737

Städtisches Krankenhaus München Neuperlach, Klinik für Onkologie und Hämatologie, Munich

115478

Russian Cancer Research Center n.a. NN Blokhin, Moscow

143423

Moscow City Oncology Hospital # 62, Chemotherapy, Moscow

197758

Scientific Centre for Specialized Medical Care (oncological), Saint Petersburg

NSW 2050

Chris O'Brien Lifehouse Oncology, Camperdown

VIC 3084

Austin Hospital Olivia Newton-John Cancer & Wellness Centre, Heidelberg

VIC 3021

Western Health, Sunshine Hospital, Saint Albans

SA 5011

The Queen Elizabeth Hospital Haematology and Oncology Unit, Woodville

14784-400

Hospital do Câncer de Barretos - Fundação Pio XII, Barretos

98700-000

Centro de Pesquisa Hospital de Caridade de Ijuí, Ijuí

20230-130

Instituto Nacional do Câncer - INCA Unidade de Pesquisa ClínicaInstituto Nacional do Câncer - INCA Unidade de Pesquisa Clínica, Rio de Janeiro

15090-000

Hospital de Base, Centro Intergrado de Pesquisa, São José do Rio Preto

01246-000

Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa, São Paulo

1105 AZ

AMC Academisch Medisch Centrum Medische Oncologie, Amsterdam

4819 EV

Amphia Ziekenhuis, Interne Geneeskunde/Oncologie, Langendijk 75, Breda

5623 EJ

Catharina Ziekenhuis, Interne Geneeskunde/Oncologie, Eindhoven

9728 NT

Martini Ziekenhuizen, Interne Geneeskunde/Oncologie, Van Swietenplein 1, Groningen

1213 XZ

Tergooi Hilversum, Medische Oncologie, Van Riebeeckweg 212, Hilversum

6162 BG

Zuyderland Medisch Centrum Interne Geneeskunde, Sittard

3543 CX

Sint Antonius Ziekenhuis Interne Geneeskunde/Oncologie, Utrecht

5912 BL

VieCurie Medisch Centrum, Interne Geneeskunde, Tegelseweg 210, Venlo

8025 AB

Isala Klinieken, Medische oncologie, Dokter Van Heeweg 2, Zwolle

81-519

Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii, Gdynia

31-531

SP ZOZ Szpital Uniwersytecki w Krakowie Oddzial Kliniczny Onkologii, Krakow

02-507

Centralny Szpital Kliniczny MSW Klinika Onkologii i Hematologii, Warsaw

04-125

NZOZ MAGODENT Oddzial Onkologii Klinicznej / Chemioterapii, Warsaw

Unknown

Russian Cancer Research Center n.a. NN Blokhin, Department of Research for New Antitumour Medicines, Moscow

08035

Hospital Valle de Hebrón, Servicio de Oncología, Barcelona

08908

Instituto Catalan De Oncología, Hospitalet de Llobregat, L'Hospitalet de Llobregat

G12 0YN

The Beatson West of Scotland Cancer Centre GI cancers, Glasgow

LE1 5WW

Leicester Royal Infirmary, The HOPE Clinical Trials Unit, Leicester

W12 0HS

Hammersmith Hospital, London

W6 8RF

Imperial healthcare NHS Trust Charing Cross Hospital, London

M20 4BX

Christie Hospital NHS Foundation Trust, GI & Endocrine, Manchester

HA6 2RN

Mount Vernon Hospital Department of Oncology, Northwood

SO16 6YD

Southampton General Hospital, Southampton

All Listed Sponsors
collaborator

ADIR, a Servier Group company

INDUSTRY

lead

Institut de Recherches Internationales Servier

OTHER

NCT02743221 - A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy | Biotech Hunter | Biotech Hunter